Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
Mary Kiige, Founder of Kikwetu Digital Solutions and Digital Innovation Strategist, has shared a post on LinkedIn:
“Can BHOC – Biological Hemoglobin Oxygen Carrier Replace Blood?
The short answer: No!
But here’s why that matters, and why it’s still revolutionary.
What BHOC cannot do:
It doesn’t replace platelets or plasma proteins.
It can’t provide clotting factors or immune cells.
It’s not a complete substitute for blood transfusion.
What BHOC can do:
Deliver oxygen instantly to tissues when red cells can’t.
Work for all blood types (no cross-matching needed).
Stay shelf-stable for 3+ years at room temperature.
Serve as a bridge therapy, buying time until blood or definitive treatment is available.
Real-world use:
Approved in South Africa since 2001.
Used under FDA Expanded Access in the U.S. for patients when blood was not an option.
Applied successfully in trauma, surgery, transplantation, and rare antibody cases.
The takeaway:
BHOC isn’t a blood replacement, it’s a lifesaving oxygen bridge.
When blood is scarce or unavailable, it creates the one thing medicine needs most: TIME!”
Stay updated with Hemostasis Today.
-
Dec 12, 2025, 14:478 Posts Not to Miss From the ASH 2025 – Marc Carrier
-
Dec 12, 2025, 10:17Alyssa George on Clinical and Economic Impact of a Eptacog Beta
-
Dec 12, 2025, 09:53Ivan Budnik Awarded AHA Postdoctoral Fellowship! Aiming to Improve DVT Long-term Outcomes
-
Dec 12, 2025, 09:34Giles Platford on Baby Big: Plasma-Derived Drug Against Infant Botulism
-
Dec 12, 2025, 09:22Matteo Foschi Presents The New Expert Guidance on Minor Ischemic Stroke
-
Dec 12, 2025, 07:00Umberto Pensato on Cancer and Stroke
-
Dec 12, 2025, 06:48Steve Tuplin on A New Era in Haemophilia A Care: Reflections from ASH25
-
Dec 12, 2025, 06:30Anirban Sen Gupta on Synthetic Platelets
-
Dec 12, 2025, 05:59Gaetan Duport: A New Legislation for Medicines in Europe
